Dipyridamole and Enoxaparin Interaction
Drug interaction information between Dipyridamole and Enoxaparin.
Dipyridamole and Enoxaparin have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Dipyridamole and Enoxaparin. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
These medicines both work to prevent blood clots in different ways, which can lead to an increased risk of bleeding when used together.
What To Do
Watch for signs of bleeding and ensure your healthcare provider is aware you are taking both medications.
FDA Label Information
These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.
Dipyridamole Also Interacts With
- Heparin moderate
- Warfarin moderate
- Adenosine minor
- Nicardipine minor
Enoxaparin Also Interacts With
- Rivaroxaban moderate
- Ketorolac minor
Frequently Asked Questions
Can I take Dipyridamole and Enoxaparin together?
This is a minor interaction. Watch for signs of bleeding and ensure your healthcare provider is aware you are taking both medications.
How serious is the interaction between Dipyridamole and Enoxaparin?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Dipyridamole and Enoxaparin interact?
These medicines both work to prevent blood clots in different ways, which can lead to an increased risk of bleeding when used together.
Understanding the Dipyridamole and Enoxaparin Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Dipyridamole belongs to the Antiplatelet / Vasodilator class and Enoxaparin belongs to the Low-Molecular-Weight Heparin class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: These medicines both work to prevent blood clots in different ways, which can lead to an increased risk of bleeding when used together. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Dipyridamole has 5 total documented interactions on file in this dataset, and Enoxaparin has 3. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Watch for signs of bleeding and ensure your healthcare provider is aware you are taking both medications. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Dipyridamole or Enoxaparin based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.